MIST - Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate.
As of May 15, 2026: spot at $1.50, ATM IV 65.5%, net GEX $55.1K.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $147.7M
- Beta
- 1.04
- 52-Week Range
- 1-3.06
- CEO
- Joseph G. Oliveto
- Employees
- 33
- IPO Date
- May 9, 2019
- Exchange
- NASDAQ
What MIST Looks Like to Options Traders Today
IV rank of 12.1% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($55.1K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.044) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The MIST overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked MIST overview questions
- What is MIST?
- MIST is the ticker symbol for Milestone Pharmaceuticals Inc., a listed security. Milestone Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. Listed on NASDAQ. MIST is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the MIST options snapshot look like today?
- As of May 15, 2026, the MIST options snapshot shows spot at $1.50, ATM IV 65.5%, IV rank 12.1%, net GEX $55.1K, expected move 18.78%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are MIST's key statistics?
- Milestone Pharmaceuticals Inc. (MIST) carries a market capitalization of $147.7M, beta of 1.04 relative to the broader market, 52-week range of 1-3.06. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does MIST belong to?
- Milestone Pharmaceuticals Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare MIST's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the MIST data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).